Profile
Michael E.
Lewis is the founder of Adolor Corp.
(1994), Cephalon, Inc. (1988), Arena Pharmaceuticals, Inc. (1997), and CARA Therapeutics, Inc. (2004).
He is currently a Director at PolyMedix Pharmaceuticals, Inc. (since 2002) and President at BioDiligence Partners, Inc. (since 1994).
He previously held positions as Director at Incara Pharmaceuticals Corp., Vice President-Research at Message Pharmaceuticals, Inc., Senior Director-Scientific Affairs at Cephalon, Inc., Director at Arena Pharmaceuticals, Inc., and Director & Chief Scientific Advisor at CARA Therapeutics, Inc. He also served as an Independent Director at PolyMedix, Inc. (2005-2013) and Aeolus Pharmaceuticals, Inc. (2011-2013).
Dr. Lewis received his undergraduate degree from George Washington University and his graduate and doctorate degrees from Clark University.
Michael Lewis active positions
| Companies | Position | Start |
|---|---|---|
PolyMedix Pharmaceuticals, Inc. | Director/Board Member | 01/08/2002 |
BioDiligence Partners, Inc. | President | 01/01/1994 |
Former positions of Michael Lewis
| Companies | Position | End |
|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | Director/Board Member | 08/05/2013 |
| POLYMEDIX, INC. | Director/Board Member | 29/03/2013 |
Incara Pharmaceuticals Corp.
Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Director/Board Member | 09/08/2004 |
| ARENA PHARMACEUTICALS | Founder | 01/01/2000 |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Founder | - |
Training of Michael Lewis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Incara Pharmaceuticals Corp.
Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Health Technology |
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
PolyMedix, Inc.
PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
CARA Therapeutics, Inc.
CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Clark University
Clark University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
PolyMedix Pharmaceuticals, Inc. | |
BioDiligence Partners, Inc. |
- Stock Market
- Insiders
- Michael Lewis
















